rewirebio.iobenchmarks
Configuration

Historical Erlangen MTB protein-function interpretation

Prior P/LP, VUS and B/LB functional-impact review; different classification semantics from oncogenicity.

1 evaluation · 2 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for Historical Erlangen MTB protein-function interpretation. Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluations and results

1 evaluation · 2 results. Different protocols are not a single leaderboard.

Protocol: OncoVI three-class assessment: MTB selected expert reassessment · Dataset: MTB selected expert reassessment

Sorted by Percent agreement (vs expert reassessment) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationPercent agreement (vs expert reassessment)Count (expert-concordant variants)
Historical Erlangen MTB protein-function interpretationEvaluation34%46
All 2 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Historical Erlangen MTB protein-function interpretationProtocol: OncoVI three-class assessment: MTB selected expert reassessment
Dataset: MTB selected expert reassessment
34% Percent agreement (vs expert reassessment)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Historical MTB agreement with expert oncogenicity reassessment

Not reported

Aggregation: Not reported

Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, validation data set, paragraph ending 46/135; Figure 4A
Configuration: Historical Erlangen MTB protein-function interpretationProtocol: OncoVI three-class assessment: MTB selected expert reassessment
Dataset: MTB selected expert reassessment
46 Count (expert-concordant variants)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Historical MTB agreement with expert oncogenicity reassessment

Not reported

Aggregation: Not reported

Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, validation data set, paragraph ending 46/135; Figure 4A

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Use this configuration

How it works, versions and access

Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Facets: method types
1 values
  • conventional_pipeline
Individual claims
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

OncoVI Methods: "an IF-ELSE implementation" of the points-based SOP

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

conflicting claim

["source-hash-verification","automated-source-review"] · 2026-10-12

Audit details

Correct the method type from none to conventional_pipeline (use-case baseline review 2026-10-12, table 2). Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. See docs/reviews/2026-10-12-method-type-corrections.md.

Conflicting source claim: "[\"conventional_pipeline\"]". Claim record status: source_checked.

Field: facets.method_types

Claim: metadata-correction-tags-20261012-728d501bd0cbc2676d64

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Extraction artifact SHA-256: 69ac0b1ef3902b1cb6461c87117db1af4b2035e6a84ab602b0c1d02fc898d28d

Extraction artifact

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20260930-oncovi-prior-mtb.

Related records

How to cite

Historical Erlangen MTB protein-function interpretation. Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/configuration/uc-clinical-20260930-oncovi-prior-mtb/

Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction